Contingency Management to Promote Smoking Cessation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Proportion of quitline calls completed
研究概览
简要总结
Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications, but patients rarely fully engage in counseling or use their cessation medications. This is a single-arm, open-label pilot study to provide feasibility metrics for a text-based contingency management (CM) intervention to increase engagement in smoking cessation treatment. All participants (N=20) will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization. The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment. The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management (CM) intervention.
详细描述
Novel approaches are needed to engage people who smoke in treatment in a way that increases their odds of quitting. Contingency management (CM) interventions provide financial incentives to participants contingent on objective evidence of behavior change and are effective in enhancing medication adherence and treatment engagement for numerous health conditions, including tobacco dependence treatment. Critical gaps, however, remain in our knowledge regarding how best to deploy CM.
The goal of this study is to evaluate the acceptability and feasibility of combined CM for engaging patients in smoking cessation treatment. Participants (N=20) will receive "CounsCM" for engaging in five quitline calls and "MedCM" for utilizing varenicline over twelve weeks. CM payments will be automated and dispensed on a daily basis using a reloadable debit card. The investigators will use surveys and structured interviews to understand strengths, weaknesses, and areas for improvement.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Smoked in the past 30 days
- •Smoke at least 1 cigarette per day when they smoke
- •≥ 18 years old
- •Kansas resident
- •Speak/read English
- •Access to a mobile phone
- •Mobile phone receives text messages
- •No varenicline contraindications (no acute renal impairment)
- •Insurance coverage for varenicline
- •Have no significant co-morbidity (i.e., life-threatening illness, communication barriers or altered mental status)
- •Cognitively able to participate
- •Physically able to participate
- •Not pregnant/breastfeeding
排除标准
- •Medically ineligible for varenicline
- •Patient on smoking cessation medication within 2 weeks of admission date
- •Patient already talked to quitline in the past 2 weeks.
- •Patients participating in other quit smoking program or research study
研究组 & 干预措施
MedCM plus CounsCM
Mobile Contingency Management for counseling attendance and medication intake
干预措施: CounsCM+MedCM (Health Rewards) (Behavioral)
结局指标
主要结局
Proportion of quitline calls completed
时间窗: Week 6
Completion of the five quitline calls over 6 weeks of treatment according to Kansas quitline reports
Proportion of varenicline pills taken
时间窗: Week 12
Varenicline intake over 12 weeks of treatment according to the smart pill dispenser counting
次要结局
- Proportion of self-reported varenicline pills taken(Week 3)
- Proportion of patients with biochemically verified smoking abstinence(Week 12)
- Proportion of patients with self-reported smoking abstinence(Week 12)
- Proportion of patients adherent to varenicline(Week 3)